Leonard Schaeffer Net Worth

The estimated Net Worth of Leonard D Schaeffer is at least $327 Thousand dollars as of 26 August 2024. Mr. Schaeffer owns over 11,347 units of scPharmaceuticals Inc stock worth over $278,245 and over the last 21 years he sold SCPH stock worth over $0. In addition, he makes $49,006 as Independent Director at scPharmaceuticals Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Schaeffer SCPH stock SEC Form 4 insiders trading

Leonard has made over 6 trades of the scPharmaceuticals Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 11,347 units of SCPH stock worth $29,275 on 26 August 2024.

The largest trade he's ever made was exercising 22,631 units of scPharmaceuticals Inc stock on 19 December 2017 worth over $37,567. On average, Leonard trades about 1,951 units every 148 days since 2004. As of 26 August 2024 he still owns at least 54,451 units of scPharmaceuticals Inc stock.

You can see the complete history of Mr. Schaeffer stock trades at the bottom of the page.

Leonard Schaeffer biography

Leonard D. Schaeffer CPA serves as Independent Director of the Company. He has served as a partner of North Bristol Partners LLC, a privately held consulting company, since 2006. From 2007 to 2011, Mr. Schaeffer served as the chairman of the Board of Surgical Care Affiliates, LLC, then a privately held company operating a national network of ambulatory surgical centers and surgical hospitals. Mr. Schaeffer formerly served as chairman of the board of WellPoint, Inc. (now Anthem, Inc.), then the largest health insurance company in the United States, chairman and chief executive officer of WellPoint Health Networks Inc. and chairman and chief executive officer of Blue Cross California and as a director of Allergan, Inc., a publicly traded specialty pharmaceutical company, from 1993 to 2011, and as a director of Amgen, Inc., a publicly traded biotechnology company, from 2004 to 2013. Mr. Schaeffer also served on the board of Walgreens Boots Alliance, a publicly traded pharmaceutical manufacturing, wholesale and distribution holding company from June 2015 to October 2019. While serving in the federal government from 1978 to 1980, Mr. Schaeffer was Administrator of the Health Care Financing Administration (now CMS) and was responsible for the United States Medicare and Medicaid programs.

What is the salary of Leonard Schaeffer?

As the Independent Director of scPharmaceuticals Inc, the total compensation of Leonard Schaeffer at scPharmaceuticals Inc is $49,006. There are 9 executives at scPharmaceuticals Inc getting paid more, with John Tucker having the highest compensation of $1,238,320.

How old is Leonard Schaeffer?

Leonard Schaeffer is 74, he's been the Independent Director of scPharmaceuticals Inc since 2014. There are no older and 10 younger executives at scPharmaceuticals Inc.

What's Leonard Schaeffer's mailing address?

Leonard's mailing address filed with the SEC is C/O SCPHARMACEUTICALS INC, 25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA, 01803.

Insiders trading at scPharmaceuticals Inc

Over the last 7 years, insiders at scPharmaceuticals Inc have traded over $5,999,254 worth of scPharmaceuticals Inc stock and bought 6,409,552 units worth $61,370,807 . The most active insiders traders include Capital Management, L.P.Ra ..., Jonathan Silverstein, and Advisors Llc Orbi Med Capit.... On average, scPharmaceuticals Inc executives and independent directors trade stock every 112 days with the average trade being worth of $1,808,281. The most recent stock trade was executed by Leonard D Schaeffer on 26 August 2024, trading 11,347 units of SCPH stock currently worth $29,275.

What does scPharmaceuticals Inc do?

scpharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (iv) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs.

Complete history of Mr. Schaeffer stock trades at AMGEN, Walgreens Boots Alliance Inc, and scPharmaceuticals Inc

scPharmaceuticals Inc executives and stock owners

scPharmaceuticals Inc executives and other stock owners filed with the SEC include:

• John Tucker,
  President, Chief Executive Officer, Principal Executive Officer, Principal Financial Officer and Director
• John H. Tucker,
  Pres, CEO, Principal Exec. Officer, Principal Financial Officer & Director
• Rachael Nokes,
  Senior Vice President - Finance, Principal Accounting Officer
• Rachael Nokes,
  Sr. VP of Fin. & Principal Accounting Officer
• Jack Khattar,
  Independent Chairman of the Board
• Frederick Hudson,
  Independent Director
• Mette Agger,
  Independent Director
• Klaus Veitinger,
  Independent Director
• Minnie Baylor-Henry,
  Independent Director
• Leonard Schaeffer,
  Independent Director
• Mason Freeman,
  Independent Director
• Katherine Taudvin,
  Director, Corporate Development, Investor Relations
• Sara Bonstein,
  Independent Director
• Michael D. Hassman,
  Sr. VP of Technical Operations
• Dr. John Mohr Pharm.D.,
  Sr. VP of Clinical Devel. & Medical Affairs
• Capital Management, Llcra C...,
  
• Invest A/S Lundbeckfond,
  10% owner
• Advisors Llc Orbi Med Capit...,
  
• Dorothy Coleman,
  Director
• Jonathan Silverstein,
  Director
• Pharmaceutical Industries L...,
  
• Troy A. Ignelzi,
  Chief Financial Officer
• Abraham Ceesay,
  Chief Operating Officer
• Kush Parmar,
  Director
• Andrew J. Schwab,
  10% owner
• Advisors Llc Orbi Med Capit...,
  
• Capital Management, L.P.Ra ...,
  
• Partners Iv, Llc5 Am Co Inv...,
  
• William Tober Abraham,